Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona / Banner University Medical Center
Tucson, Arizona, United States
- University of California, San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- University of Colorado (ucd) Anschutz
Aurora, Colorado, United States
- Harvard University / Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Duke University
Durham, North Carolina, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Brown University/rhode Island Hospital
Providence, Rhode Island, United States
- University of Texas Southwestern
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2026
- Primary completion
- 28 Feb 2030
- Completion
- 31 Mar 2030
- Last update posted
- 22 May 2026
- Registered enrollment
- 90
- Registry id
- NCT07601295
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.